SCHEMBL6478625

SCHEMBL6478625

COc1cc2cnc(Nc3ccc(Cl)cc3F)nc2cc1O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.51
RAF1 P04049 1/20 0.51
BRAF P15056 1/20 0.51
FLT1 P17948 7/20 0.48
KDR P35968 6/20 0.48
FGFR1 P11362 5/20 0.48
FLT4 P35916 2/20 0.48
EPHB2 P29323 1/20 0.48
NUDT1 P36639 3/20 0.47
CSF1R P07333 1/20 0.47
ERBB2 P04626 1/20 0.46
SRC P12931 1/20 0.46
FGFR4 P22455 1/20 0.42
ALK Q9UM73 1/20 0.42
SYK P43405 1/20 0.41
LRRK2 Q5S007 1/20 0.41
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
KMT2A Q03164 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5446668 0.88 RAF1 (0.50) EGFRRAF1BRAFFLT1KDR
SCHEMBL6478589 0.87 KDR (0.49) EGFRRAF1BRAFFLT1KDR
SCHEMBL31590008 0.83 FGFR4 (0.42) EGFRRAF1BRAFFGFR1ERBB2
SCHEMBL6971358 0.79 EPHA2 (0.53) EGFRFLT1KDRFGFR1FLT4
SCHEMBL30602465 0.78 EGFR (0.51) EGFRRAF1BRAFKDRFLT4
SCHEMBL6880173 0.77 KDR (0.50) EGFRRAF1BRAFFLT1KDR
SCHEMBL4921113 0.77 CSF1R (0.51) EGFRKDRFGFR1CSF1RFGFR4
SCHEMBL7797258 0.77 KDR (0.59) EGFRFLT1KDRFGFR1FLT4
SCHEMBL1891633 0.76 FLT1 (0.70) EGFRRAF1BRAFFLT1KDR
SCHEMBL8711202 0.76 RAF1 (0.37) EGFRRAF1BRAFFLT1KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6897210-B2 Quinazoline derivatives and pharmaceutical compositions containing them ZENECA LIMITED (GB) 2005-05-24 US disclosed
EP-1244647-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS AstraZeneca AB (SE) 2002-10-02 EP disclosed
WO-2001032651-A1 QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS ASTRAZENECA AB (SE) 2001-05-10 WO disclosed
EP-0929530-A1 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1999-07-21 EP disclosed
WO-1998013354-A1 QUINAZOLINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM ZENECA LIMITED (GB) 1998-04-02 WO disclosed